SGLT2 inhibition: miracle drugs for the heart, kidney and diabetes
City
Webinar
Type of event
virtual
Invitation
Dear Dr.
The Zurich Heart House would like to invite you to a special webinar on
SGLT2 inhibition: miracle drugs for the heart, kidney and diabetes
Date: Thursday, September 7th, 2023, 17:00 – 18:30 CET
We are looking forward to meeting you during this webinar.
Thomas F. Lüscher, Zurich and London
Felix Beuschlein, Zurich
Jürg Beer, Baden
Programme
Chairs: Felix Beuschlein, Zurich, Jürg Beer, Baden and Thomas F. Lüscher London/Zurich
| 17:00 | 2023 ESC Heart Failure Guidelines Update | Theresa McDonagh, London |
| 17:15 | A heart failure drug independent of LVEF? | Milton Packer, Dallas |
| 17:30 | From the heart to the kidney: SGLT2 in chronic renal failure | Christoph Wanner, Würzburg |
| 17:45 | Back to the first indication; SGLT2 inhibitors in diabetes | Marc Donath, Basel |
| 18:00 | Panel discussion: An approach for the patient with multimorbidity | |
| 18:30 | End of webinar |
The programme may be subject to change.
Accreditation
This webinar has been accredited by the European Accreditation Council for Continuing Medical Education (EACCME®) with 1 European CME credits (ECMEC®s).
Organized by
